Above you can see the drugs for the treatment of cancer marketed by Mundipharma in Denmark.

Focus on two cancers

Cancer is not one disease, but a collective term for many diseases.

Common to them all is that cell growth and cell division have grown out of control. Mundipharma focuses on the treatment of two cancer types – leukaemia and lymphoma.
Leukaemia – or blood cancer – is caused by changes in the DNA in the stem cells which form blood. The changes stop the blood’s stem cells from forming new normal blood cells. The disease occurs in a number of variations, and each individual disease type displays itself in various different ways.

Mundipharma also works on the treatment of lymphoma which belongs to the class of cancer diseases, that occur in that component of white cells called lymphocytes, which are found in the body’s lymph nodes.

This site is intended for Danish audiences only.

Depocyte®

Obtain information about Depocyte® here:

Min medicin

Product leaflet

Product summary

 

This site is intended for Danish audiences only.

Levact®

Obtain information about Levact® here:

Min medicin

Product leaflet

Product summary

 

This site is intended for Danish audiences only.

© 2018 Mundipharma A/S

Address

Mundipharma A/S
Frydenlundsvej 30, Building E,
2950 Vedbæk - Denmark

Contact

Phone: +45 45 17 48 00
Fax: +45 45 17 48 29
Monday - Friday at 9.00 - 16.00
mundipharma@mundipharma.dk

About Mundipharma

Mundipharma A/S is a part of Purdue/Mundipharma/Napp, which is an international network of independent associated medical companies.

Conditions for the use of Mundipharma.dk